Background illustration for clinical trials search

Paid Clinical Trials Orange County

Discover 3,617 paid clinical trials in Orange County, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

for
Psychosis Associated With Alzheimer's Disease
Location: Anaheim CA, Pasadena CA, Los Angeles CA,
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Sex: All

Age: 55 - 70+

Code: NCT05980949

Phase 3, Recruiting

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

for
Migraine
Location: Anaheim CA, La Palma CA, Winnetka CA, Oceanside CA,
Sponsor: AbbVie

Sex: All

Age: 6 - 17

Code: NCT05125302

Phase 3, Recruiting

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

for
Pediatric Migraine
Location: Anaheim CA, Fountain Valley CA, Costa Mesa CA,
Sponsor: Pfizer

Sex: All

Age: 6 - 17

Code: NCT04649242

Phase 3, Recruiting

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

for
Acute Treatment of Migraine
Location: Anaheim CA, Long Beach CA, Pomona CA, La Jolla CA,
Sponsor: Pfizer

Sex: All

Age: 6 - 17

Code: NCT04743141

Phase 3, Recruiting

A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

for
Episodic Migraine
Location: Anaheim CA, Long Beach CA, San Jose CA, Walnut Creek CA,
Sponsor: AbbVie

Sex: All

Age: 6 - 17

Code: NCT05711394

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients

for
Pediatric Chronic Inflammatory Demyelinating Polyneuropathy
Location: Orange CA, Houston TX, Birmingham AL, Louisville KY,
Sponsor: Octapharma

Sex: All

Age: 2 - 17

Code: NCT04929236

Phase 3, Recruiting

A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)

for
Focal Segmental Glomerulosclerosis
Location: Garden Grove CA, San Dimas CA, Los Angeles CA,
Sponsor: Akebia Therapeutics

Sex: All

Age: 18+

Code: NCT07268638

Phase 2, Recruiting

A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome

for
Myelodysplastic Syndromes
Location: Irvine CA, Duarte CA, Goodyear AZ, Houston TX,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06847867

Phase 2, Recruiting

Study of Olverembatinib (HQP1351) in Patients With CML-CP

for
Chronic Myeloid Leukemia, CML, CML, Chronic Phase
Location: Irvine CA, Long Beach CA, Upland CA, Duarte CA,
Sponsor: Ascentage Pharma Group Inc.

Sex: All

Age: 18+

Code: NCT06423911

Phase 3, Recruiting

A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

for
Parkinson Disease
Location: Irvine CA, Los Angeles CA, Sun City AZ, Aurora CO,
Sponsor: Biohaven Therapeutics Ltd.

Sex: All

Age: 40 - 70+

Code: NCT06976268

Phase 2, Phase 3, Recruiting

Venous Obstruction in Neurodegenerative Disorders Research Registry

for
Chronic Cerebral Spinal Venous Insufficiency
Location: Newport Beach CA
Sponsor: Synergy Health Concepts, Inc.

Sex: All

Age: 18 - 70+

Code: NCT01593358

Recruiting

Venous Irregularities, Flow and Perfusion in MS Study

for
Venous Irregularities, Flow and Perfusion in MS and Non-MS Participants,
Location: Newport Beach CA
Sponsor: Synergy Health Concepts, Inc.

Sex: All

Age: 20 - 65

Code: NCT01593904

Recruiting
New

A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05)

for
Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer
Location: Fountain Valley CA, Fort Worth TX, Orlando FL,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT07743164

Phase 3, Recruiting

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

for
Hormone Receptor Positive HER-2 Negative Breast Cancer,
Location: Fountain Valley CA, Irvine CA, Los Angeles CA,
Sponsor: Puma Biotechnology, Inc.

Sex: All

Age: 18+

Code: NCT06369285

Phase 2, Recruiting

SuperSaturated Oxygen Comprehensive Observational Registry

for
STEMI - ST Elevation Myocardial Infarction, AMI
Location: Fountain Valley CA, Laguna Hills CA, Long Beach CA,
Sponsor: TherOx

Sex: All

Age: 18 - 70+

Code: NCT06438315

Recruiting

Galleri® in the Medicare Population.

for
Cancer
Location: Fountain Valley CA, Laguna Hills CA, Long Beach CA,
Sponsor: GRAIL, Inc.

Sex: All

Age: 50+

Code: NCT05673018

Recruiting

A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

for
mCRPC (Metastatic Castration-resistant Prostate Cancer),
Location: Fountain Valley CA, Los Alamitos CA, Aurora CO,
Sponsor: Pathos AI, Inc.

Sex: Male

Age: 18+

Code: NCT06785636

Phase 1, Phase 2, Recruiting

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

for
Triple-Negative Breast Cancer
Location: Fountain Valley CA, Oceanside CA, La Jolla CA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06393374

Phase 3, Recruiting

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

for
Prostatic Neoplasms, Castration-Resistant
Location: Fountain Valley CA, Los Alamitos CA, Riverside CA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07225946

Phase 3, Recruiting

A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer)

for
Early Breast Cancer
Location: Fountain Valley CA, Clovis CA, Stockton CA, Reno NV,
Sponsor: Genentech, Inc.

Sex: Female

Age: 18+

Code: NCT07541079

Phase 3, Recruiting